Abstract:Aim: To study the effect of NO donating-benzopyran compound - II-7 on the awake spontaneously hypertensive rats (SHR) and the nitric oxide (NO) release in vitro. Methods: Systolic artery pressure (SAP), diastolic artery pressure(DAP) and heart rate(HR) were measured after single oral administration and 7-day repeated oral administration of II-7. The quantity of NO releasing was determined by Griess method. Results: Single oral administration of II-7 at 6.0 mg/kg decreased the SAP and DAP very significantly (P < 0.01 vs control) while increasing the HR remarkably (P < 0.05 vs control). After 7-day repeated administration of II-7 (6.0,2.0 mg/kg), with no difference in SAP and DAP being observed in the 2.0 mg/kg group (P > 0.05 vs control), the compound showed a dose-dependent effect while those of the 6.0 mg/kg group were decreased very significantly (P < 0.01 vs control). It was also found that NO was slowly released and even remained at a rather stable level between 0.265 - 0.284 μg/mL in 2.5 h with the maximal release of 0.286 μg/mL being reached. Conclusion: Single or 7-day repeated oral administration of NO donating-benzopyran compound II-7 could significantly decrease the blood pressure of SHR release NO slowly while remaining at a rather stable level in vitro.

Study on NO-donating antihypertensive agents I. Synthesis and antihypertensive activity of C-3 nitrate or furoxan substituted benzopyrans

Study on NO-Donating Antihypertensive AgentsI. Synthesis and Antihypertensive Activity of C-3 Nitrate or Furoxan Substituted Benzopyrans

Synthesis and anti-hypertensive activity of C-4 substituted NO-donating benzopyran derivatives

Novel Nitric Oxide-Releasing Isochroman-4-one Derivatives: Synthesis and Evaluation of Antihypertensive Activity.

Design, Synthesis and Pharmacological Evaluation of Novel NO-Releasing Benzimidazole Hybrids as Potential Antihypertensive Candidate.

[Design, Synthesis and Antiasthmatic Activities of NO-donating Seratrodast Derivatives].

Synthesis and Biological Evaluations of Novel Nitric Oxide-donating Derivatives of [1,2,4]triazol-5(4H)-one with N-phenylpyrrolyl-2-tetrazole Moiety as Anti-hypertension Candidates

Synthesis and Biological Study of 3-Butyl-1-(2,6-dichlorophenyl)-1h-[1,2,4]triazol-5(4h)-one Derivatives As Anti-Hypertension Drugs

Synthesis and Biological Activities of Oxaprozin Derivatives

Effect of NO donating-benzopyran compound II-7 on spontaneously hypertensive rats and NO releasing in vitro

Design, synthesis and biological evaluation of novel fluoro-substituted benzimidazole derivatives with anti-hypertension activities

Design, Synthesis and Biological Evaluation of Isochroman-4-one Hybrids Bearing Piperazine Moiety As Antihypertensive Agent Candidates

Synthesis and Vascular Relaxing Activity of Arecoline Derivatives Coupled with Nitric Oxide Donors

Design, Synthesis and Biological Evaluation of Hydrogen Sulfide-Releasing Isochroman-4-one Derivatives As New Antihypertensive Agent Candidates.

Synthesis and Antihypertensive Activity Evaluation in Spontaneously Hypertensive Rats of Nitrendipine Analogues

Synthesis and Antitumor Activity of Nitric Oxide Releasing Derivatives of AT1 Antagonist

Discovery of Novel 3-Benzylquinazolin-4(3 H )-Ones As Potent Vasodilative Agents

Design, Synthesis, and Biological Evaluation of 1,2,4-Triazole Bearing 5-Substituted Biphenyl-2-sulfonamide Derivatives As Potential Antihypertensive Candidates

Discovery of Novel 2-Benzylisoquinolin-1(2h)-ones As Potent Vasodilative Agents

Novel hybrids of natural isochroman-4-one bearing N-substituted isopropanolamine as potential antihypertensive candidates.

Design, Synthesis and Biological Evaluation of 6-Substituted Aminocarbonyl Benzimidazole Derivatives As Nonpeptidic Angiotensin II AT1 Receptor Antagonists.